903 related articles for article (PubMed ID: 27417338)
1. Randomised clinical trial: low-FODMAP rye bread vs. regular rye bread to relieve the symptoms of irritable bowel syndrome.
Laatikainen R; Koskenpato J; Hongisto SM; Loponen J; Poussa T; Hillilä M; Korpela R
Aliment Pharmacol Ther; 2016 Sep; 44(5):460-70. PubMed ID: 27417338
[TBL] [Abstract][Full Text] [Related]
2. Low-FODMAP
Pirkola L; Laatikainen R; Loponen J; Hongisto SM; Hillilä M; Nuora A; Yang B; Linderborg KM; Freese R
World J Gastroenterol; 2018 Mar; 24(11):1259-1268. PubMed ID: 29568206
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal tolerance of low FODMAP oral nutrition supplements in healthy human subjects: a randomized controlled trial.
Erickson J; Korczak R; Wang Q; Slavin J
Nutr J; 2017 May; 16(1):35. PubMed ID: 28545589
[TBL] [Abstract][Full Text] [Related]
4. Low fermentable oligo-di-mono-saccharides and polyols diet versus general dietary advice in patients with diarrhea-predominant irritable bowel syndrome: A randomized controlled trial.
Zahedi MJ; Behrouz V; Azimi M
J Gastroenterol Hepatol; 2018 Jun; 33(6):1192-1199. PubMed ID: 29159993
[TBL] [Abstract][Full Text] [Related]
5. Low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet improves symptoms in adults suffering from irritable bowel syndrome (IBS) compared to standard IBS diet: A meta-analysis of clinical studies.
Varjú P; Farkas N; Hegyi P; Garami A; Szabó I; Illés A; Solymár M; Vincze Á; Balaskó M; Pár G; Bajor J; Szűcs Á; Huszár O; Pécsi D; Czimmer J
PLoS One; 2017; 12(8):e0182942. PubMed ID: 28806407
[TBL] [Abstract][Full Text] [Related]
6. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.
Halmos EP; Power VA; Shepherd SJ; Gibson PR; Muir JG
Gastroenterology; 2014 Jan; 146(1):67-75.e5. PubMed ID: 24076059
[TBL] [Abstract][Full Text] [Related]
7. Does Fibre-fix provided to people with irritable bowel syndrome who are consuming a low FODMAP diet improve their gut health, gut microbiome, sleep and mental health? A double-blinded, randomised controlled trial.
Yan R; Murphy M; Genoni A; Marlow E; Dunican IC; Lo J; Andrew L; Devine A; Christophersen CT
BMJ Open Gastroenterol; 2020 Aug; 7(1):. PubMed ID: 32816830
[TBL] [Abstract][Full Text] [Related]
8. Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis.
Marsh A; Eslick EM; Eslick GD
Eur J Nutr; 2016 Apr; 55(3):897-906. PubMed ID: 25982757
[TBL] [Abstract][Full Text] [Related]
9. Randomised clinical trial: effect of low-FODMAP rye bread versus regular rye bread on the intestinal microbiota of irritable bowel syndrome patients: association with individual symptom variation.
Laatikainen R; Jalanka J; Loponen J; Hongisto SM; Hillilä M; Koskenpato J; Korpela R; Salonen A
BMC Nutr; 2019; 5():12. PubMed ID: 32153925
[TBL] [Abstract][Full Text] [Related]
10. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial.
Böhn L; Störsrud S; Liljebo T; Collin L; Lindfors P; Törnblom H; Simrén M
Gastroenterology; 2015 Nov; 149(6):1399-1407.e2. PubMed ID: 26255043
[TBL] [Abstract][Full Text] [Related]
11. A Randomized Controlled Trial Comparing the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D.
Eswaran SL; Chey WD; Han-Markey T; Ball S; Jackson K
Am J Gastroenterol; 2016 Dec; 111(12):1824-1832. PubMed ID: 27725652
[TBL] [Abstract][Full Text] [Related]
12. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome.
Staudacher HM; Whelan K; Irving PM; Lomer MC
J Hum Nutr Diet; 2011 Oct; 24(5):487-95. PubMed ID: 21615553
[TBL] [Abstract][Full Text] [Related]
13. Fermentable oligo-, di-, monosaccharides, and polyols (FODMAPs), but not gluten, elicit modest symptoms of irritable bowel syndrome: a double-blind, placebo-controlled, randomized three-way crossover trial.
Nordin E; Brunius C; Landberg R; Hellström PM
Am J Clin Nutr; 2022 Feb; 115(2):344-352. PubMed ID: 34617561
[TBL] [Abstract][Full Text] [Related]
14. Effect of Structural Individual Low-FODMAP Dietary Advice vs. Brief Advice on a Commonly Recommended Diet on IBS Symptoms and Intestinal Gas Production.
Patcharatrakul T; Juntrapirat A; Lakananurak N; Gonlachanvit S
Nutrients; 2019 Nov; 11(12):. PubMed ID: 31766497
[TBL] [Abstract][Full Text] [Related]
15. Nutrient Intake, Diet Quality, and Diet Diversity in Irritable Bowel Syndrome and the Impact of the Low FODMAP Diet.
Staudacher HM; Ralph FSE; Irving PM; Whelan K; Lomer MCE
J Acad Nutr Diet; 2020 Apr; 120(4):535-547. PubMed ID: 31029650
[TBL] [Abstract][Full Text] [Related]
16. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome.
Ong DK; Mitchell SB; Barrett JS; Shepherd SJ; Irving PM; Biesiekierski JR; Smith S; Gibson PR; Muir JG
J Gastroenterol Hepatol; 2010 Aug; 25(8):1366-73. PubMed ID: 20659225
[TBL] [Abstract][Full Text] [Related]
17. Low FODMAP diet reduces gastrointestinal symptoms in irritable bowel syndrome and clinical response could be predicted by symptom severity: A randomized crossover trial.
Algera JP; Demir D; Törnblom H; Nybacka S; Simrén M; Störsrud S
Clin Nutr; 2022 Dec; 41(12):2792-2800. PubMed ID: 36384081
[TBL] [Abstract][Full Text] [Related]
18. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome.
Chumpitazi BP; Cope JL; Hollister EB; Tsai CM; McMeans AR; Luna RA; Versalovic J; Shulman RJ
Aliment Pharmacol Ther; 2015 Aug; 42(4):418-27. PubMed ID: 26104013
[TBL] [Abstract][Full Text] [Related]
19. The role of FODMAPs in irritable bowel syndrome.
Shepherd SJ; Halmos E; Glance S
Curr Opin Clin Nutr Metab Care; 2014 Nov; 17(6):605-9. PubMed ID: 25255126
[TBL] [Abstract][Full Text] [Related]
20. A low FODMAP diet plus traditional dietary advice versus a low-carbohydrate diet versus pharmacological treatment in irritable bowel syndrome (CARIBS): a single-centre, single-blind, randomised controlled trial.
Nybacka S; Törnblom H; Josefsson A; Hreinsson JP; Böhn L; Frändemark Å; Weznaver C; Störsrud S; Simrén M
Lancet Gastroenterol Hepatol; 2024 Jun; 9(6):507-520. PubMed ID: 38643782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
